sellModerate cluster of 5
D'AMICO LANCE E sold $5.2M of APH
Sr. VP, Secretary & GenCounsel at AMPHENOL CORP /DE/. 75,000 shares at an average of $68.80, traded Oct 30, 2024, filed Oct 31, 2024.
Warning score
50Value
$5.2M
75,000 shares
Holdings after
76,400
-50% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001127602-24-026153, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 29, 2024 | MOption exercise Class A Common Stock | +100,000 | $22.00 | $2.2M | 151,400 | Oct 31, 2024 |
| Oct 30, 2024 | SOpen-market sale Class A Common Stock | -75,000 | $68.80 | $5.2M | 76,400 | Oct 31, 2024 |
| Oct 29, 2024 | MOption exercise Stock Optionderivative | -100,000 | $0.00 | $0 | 0 | Oct 31, 2024 |
Related signals
Other insiders at AMPHENOL CORP /DE/ and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 65Notable | sell 5 | APH AMPHENOL CORP /DE/ | Straub Peter President, ISS Division | $9.8M | 132,000 | |
| 57Moderate | sell 5 | APH AMPHENOL CORP /DE/ | Lampo Craig A SR VP & CFO | $21M | 300,000 | |
| 60Notable | sell 5 | APH AMPHENOL CORP /DE/ | Silverman David M Senior VP, Human Resources | $13M | 180,000 | |
| 60Notable | sell 5 | APH AMPHENOL CORP /DE/ | NORWITT RICHARD ADAM President & CEO | $82M | 1,190,000 | |
| 57Moderate | sell 5 | APH AMPHENOL CORP /DE/ | Lampo Craig A SR VP & CFO | $10M | 150,000 | |
| 60Notable | sell 5 | APH AMPHENOL CORP /DE/ | Silverman David M Senior VP, Human Resources | $12M | 180,000 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.